EPCAM and hepatocellular carcinoma: In order to verify the capture efficiency of GPC3-IML, the nano-immunoliposomes coated with EpCAM, Vimentin and GPC3 were tested on two GPC3-positive HCC cell lines (MHCC97-L cell line and Huh-7 cell line).